| scholarly article | Q13442814 |
| P2093 | author name string | M P Peppelenbosch | |
| B van den Blink | |||
| I Pronk | |||
| P Drillenburg | |||
| S J H van Deventer | |||
| T ten Hove | |||
| P2860 | cites work | A protein kinase involved in the regulation of inflammatory cytokine biosynthesis | Q24311139 |
| The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor | Q24563111 | ||
| A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells | Q28237789 | ||
| Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine | Q28287650 | ||
| Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3 (Mkk3)-deficient mice | Q28509000 | ||
| p38 MAPK signalling cascades in inflammatory disease | Q28678986 | ||
| A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins | Q29617438 | ||
| A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis | Q29619339 | ||
| SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1 | Q29620495 | ||
| Interferon-gamma expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway | Q33888844 | ||
| p38 MAP kinase mediates bax translocation in nitric oxide-induced apoptosis in neurons | Q36334008 | ||
| Inflammatory bowel disease (1) | Q37278321 | ||
| Activation of p38 mitogen-activated protein kinase in vivo selectively induces apoptosis of CD8(+) but not CD4(+) T cells | Q39450773 | ||
| Phenotypic and functional heterogeneity of CD4+ T cells | Q39473418 | ||
| Current concepts of the pathogenesis of inflammatory bowel disease | Q40584499 | ||
| Cytokines in intestinal inflammation: pathophysiological and clinical considerations. | Q40810565 | ||
| T cell activation signals up-regulate p38 mitogen-activated protein kinase activity and induce TNF-alpha production in a manner distinct from LPS activation of monocytes. | Q40978696 | ||
| T cell proliferation in response to interleukins 2 and 7 requires p38MAP kinase activation. | Q41105516 | ||
| Mitogen-activated protein (MAP) kinase regulates production of tumor necrosis factor-alpha and release of arachidonic acid in mast cells. Indications of communication between p38 and p42 MAP kinases | Q41109906 | ||
| A p38 MAP kinase inhibitor SB203580 inhibits CD28-dependent T cell proliferation and IL-2 production | Q41112102 | ||
| Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease. | Q41113522 | ||
| Tumour necrosis factor and Crohn's disease | Q41491900 | ||
| Tumour necrosis factor and inflammatory bowel disease | Q41581913 | ||
| Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site | Q42550034 | ||
| Hapten-induced colitis is associated with colonic patch hypertrophy and T helper cell 2-type responses | Q42944018 | ||
| An interleukin 12-related cytokine is up-regulated in ulcerative colitis but not in Crohn's disease | Q43478061 | ||
| Differential roles of ERK and p38 MAP kinase pathways in positive and negative selection of T lymphocytes. | Q44556255 | ||
| Inflammatory bowel disease: etiology and pathogenesis | Q47899867 | ||
| Evidence of a central role for p38 map kinase induction of tumor necrosis factor alpha in pancreatitis-associated pulmonary injury. | Q50517258 | ||
| Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice. | Q54074094 | ||
| Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice | Q59276550 | ||
| Role of Interleukin (IL)-2 Receptor β-Chain Subdomains and Shc in p38 Mitogen-activated Protein (MAP) Kinase and p54 MAP Kinase (Stress-activated Protein Kinase/c-Jun N-terminal Kinase) Activation | Q60683152 | ||
| p38 Mitogen-Activated Protein Kinase Inhibition Increases Cytokine Release by Macrophages In Vitro and During Infection In Vivo | Q63916239 | ||
| Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function | Q71901083 | ||
| p38 mitogen-activated protein kinase regulates human T cell IL-5 synthesis | Q73098769 | ||
| Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis | Q73374754 | ||
| Role of p38 mitogen-activated protein kinase in a murine model of pulmonary inflammation | Q73407117 | ||
| SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence | Q73586335 | ||
| Hapten-induced colitis associated with maintained Th1 and inflammatory responses in IFN-gamma receptor-deficient mice | Q73812520 | ||
| Pharmacological effects of SB 220025, a selective inhibitor of P38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models | Q74138408 | ||
| A specific inhibitor of the p38 mitogen activated protein kinase affects differentially the production of various cytokines by activated human T cells: dependence on CD28 signaling and preferential inhibition of IL-10 production | Q74624937 | ||
| p38 mitogen-activated protein kinase mediates signal integration of TCR/CD28 costimulation in primary murine T cells | Q77320317 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colitis | Q2453464 |
| P304 | page(s) | 507-512 | |
| P577 | publication date | 2002-04-01 | |
| P1433 | published in | Gut | Q5621669 |
| P1476 | title | Dichotomal role of inhibition of p38 MAPK with SB 203580 in experimental colitis | |
| P478 | volume | 50 |
| Q36344230 | A Picrorhiza kurroa derivative, picroliv, attenuates the development of dextran-sulfate-sodium-induced colitis in mice |
| Q56774085 | A novel cell type-specific role of p38α in the control of autophagy and cell death in colorectal cancer cells |
| Q40542036 | Aeromonas hydrophila cytotoxic enterotoxin activates mitogen-activated protein kinases and induces apoptosis in murine macrophages and human intestinal epithelial cells |
| Q43039154 | Amelioration of dextran sulfate sodium-induced colitis by neuropeptide Y antisense oligodeoxynucleotide |
| Q37454723 | An FcRn-dependent role for anti-flagellin immunoglobulin G in pathogenesis of colitis in mice. |
| Q39411710 | Butyrate enhancement of inteleukin-1β production via activation of oxidative stress pathways in lipopolysaccharide-stimulated THP-1 cells |
| Q37290683 | Colon-targeted delivery of live bacterial cell biotherapeutics including microencapsulated live bacterial cells. |
| Q44361949 | Curcumin attenuates DNB-induced murine colitis. |
| Q43003997 | Differential modulation of p38 mitogen activated protein kinase and STAT3 signalling pathways by infliximab and etanercept in intestinal T cells from patients with Crohn's disease |
| Q33759080 | Distinct effects of p38alpha deletion in myeloid lineage and gut epithelia in mouse models of inflammatory bowel disease. |
| Q42929133 | Down-regulation of p38 mitogen-activated protein kinase activation and proinflammatory cytokine production by mitogen-activated protein kinase inhibitors in inflammatory bowel disease. |
| Q33678034 | Essential turmeric oils enhance anti-inflammatory efficacy of curcumin in dextran sulfate sodium-induced colitis |
| Q42566177 | FR167653, a p38 mitogen-activated protein kinase inhibitor, aggravates experimental colitis in mice |
| Q51769753 | Hookworm products ameliorate dextran sodium sulfate-induced colitis in BALB/c mice. |
| Q33521275 | IL-2 regulates SEB induced toxic shock syndrome in BALB/c mice |
| Q40653906 | Induced stabilization of IκBα can facilitate its re‐synthesis and prevent sequential degradation |
| Q40225845 | Induction by activated macrophage-like THP-1 cells of apoptotic and necrotic cell death in intestinal epithelial Caco-2 monolayers via tumor necrosis factor-alpha |
| Q40448426 | Inhibition of RICK/nuclear factor-kappaB and p38 signaling attenuates the inflammatory response in a murine model of Crohn disease. |
| Q35083367 | Inhibition of p38 mitogen-activated protein kinase augments progression of remnant kidney model by activating the ERK pathway |
| Q34233126 | Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease |
| Q40680288 | Interferon-gamma induces C/EBP beta expression and activity through MEK/ERK and p38 in T84 colon epithelial cells. |
| Q35668327 | Interleukin-10 Enhances the Intestinal Epithelial Barrier in the Presence of Corticosteroids through p38 MAPK Activity in Caco-2 Monolayers: A Possible Mechanism for Steroid Responsiveness in Ulcerative Colitis |
| Q45942633 | MDP-Induced selective tolerance to TLR4 ligands: impairment in NOD2 mutant Crohn's disease patients. |
| Q35023644 | Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets. |
| Q37605958 | Mitogen activated protein kinases: a role in inflammatory bowel disease? |
| Q34783518 | Multiparametric and semiquantitative scoring systems for the evaluation of mouse model histopathology--a systematic review |
| Q61398520 | No Evidence for an Involvement of the P38 and JNK Mitogen-Activated Protein in Inflammatory Bowel Diseases |
| Q51132126 | P38 MAPK Pharmacological Inhibitor SB203580 Alleviates Total Parenteral Nutrition-Induced Loss of Intestinal Barrier Function but Promotes Hepatocyte Lipoapoptosis. |
| Q35145112 | PAF receptor antagonist Ginkgolide B inhibits tumourigenesis and angiogenesis in colitis-associated cancer |
| Q38344721 | Physiologically based pharmacokinetics of molecular imaging nanoparticles for mRNA detection determined in tumor-bearing mice. |
| Q50764045 | Reduced p38 mitogen-activated protein kinase in donor grafts accelerates acute intestinal graft-versus-host disease in mice. |
| Q36467014 | Regulation of apoptosis during homeostasis and disease in the intestinal epithelium |
| Q91705312 | Renoprotective Effects Of Isoliquiritin Against Cationic Bovine Serum Albumin-Induced Membranous Glomerulonephritis In Experimental Rat Model Through Its Anti-Oxidative And Anti-Inflammatory Properties |
| Q36893499 | Repression of the genome organizer SATB1 in regulatory T cells is required for suppressive function and inhibition of effector differentiation |
| Q37992246 | Results of the 2nd scientific workshop of the ECCO (III): basic mechanisms of intestinal healing. |
| Q35171811 | Review article: mitogen-activated protein kinases in chronic intestinal inflammation - targeting ancient pathways to treat modern diseases |
| Q40554777 | Safety characterization and antimicrobial properties of kefir-isolated Lactobacillus kefiri |
| Q35144028 | Targeting cytokines in autoimmunity: new approaches, new promise |
| Q46441519 | Tetrandrine ameliorates dextran-sulfate-sodium-induced colitis in mice through inhibition of nuclear factor -kappaB activation |
| Q34285206 | Tgfbeta signaling directly induces Arf promoter remodeling by a mechanism involving Smads 2/3 and p38 MAPK. |
| Q37940031 | The role of p38 mitogen-activated protein kinase in the pathogenesis of inflammatory bowel disease |
| Q83185411 | The specific JNK inhibitor SP600125 targets tumour necrosis factor-alpha production and epithelial cell apoptosis in acute murine colitis |
| Q84512199 | Therapeutic effect of antisecretory factor-rich egg yolk on the late phases of 2,4,6-trinitrobenzenesulphonic acid colitis in mice |
| Q41827848 | Therapeutic efficacy and mechanism of Zhenrenyangzang decoction in rats with experimental ulcerative colitis |
| Q35787657 | Therapeutic modulation of signal transduction pathways. |
| Q43006397 | Uncoupling the p38 MAPK kinase in IBD: a double edged sword? |
| Q36003240 | mTOR Inhibition Attenuates Dextran Sulfate Sodium-Induced Colitis by Suppressing T Cell Proliferation and Balancing TH1/TH17/Treg Profile |
| Q41093716 | p38 kinase regulates epidermal growth factor receptor downregulation and cellular migration |
Search more.